Invention Application
US20170008844A1 (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
有权
（HETERO）ARYL CYPOPRAMLAMINE COMPOUNDS AS LSD1 INHIBITORS
- Patent Title: (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
- Patent Title (中): （HETERO）ARYL CYPOPRAMLAMINE COMPOUNDS AS LSD1 INHIBITORS
-
Application No.: US15271772Application Date: 2016-09-21
-
Publication No.: US20170008844A1Publication Date: 2017-01-12
- Inventor: Alberto ORTEGA MUÑOZ , Matthew Colin Thor FYFE , Marc MARTINELL PEDEMONTE , Maria de los Àngeles ESTIARTE MARTINEZ , Nuria VALLS VIDAL , Guido KURZ , Julio Cesar CASTRO PALOMINO LARIA
- Applicant: Oryzon Genomics, S.A.
- Priority: EP11382325.6 20111020; EP11382331.4 20111027
- Main IPC: C07D211/58
- IPC: C07D211/58 ; C07D405/12 ; C07D309/04 ; C07D211/56 ; C07D207/14 ; C07D205/04 ; C07D451/04 ; C07D221/20 ; C07D215/42 ; C07D401/12 ; C07D417/12 ; C07D401/04 ; C07D335/02 ; C07D223/12 ; C07D211/26
Abstract:
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
Public/Granted literature
- US09944601B2 (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Public/Granted day:2018-04-17
Information query
